339 related articles for article (PubMed ID: 35409328)
21. Identification of host genomic biomarkers from multiple transcriptomics datasets for diagnosis and therapies of SARS-CoV-2 infections.
Sarker B; Rahaman MM; Islam MA; Alamin MH; Husain MM; Ferdousi F; Ahsan MA; Mollah MNH
PLoS One; 2023; 18(3):e0281981. PubMed ID: 36913345
[TBL] [Abstract][Full Text] [Related]
22. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
[TBL] [Abstract][Full Text] [Related]
23. Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer.
Liu X; Liu X; Li J; Ren F
Med Sci Monit; 2019 Dec; 25():9280-9289. PubMed ID: 31805030
[TBL] [Abstract][Full Text] [Related]
24. Screening and Identification of Key Biomarkers in Inflammatory Breast Cancer Through Integrated Bioinformatic Analyses.
Wu J; Lv Q; Huang H; Zhu M; Meng D
Genet Test Mol Biomarkers; 2020 Aug; 24(8):484-491. PubMed ID: 32598242
[No Abstract] [Full Text] [Related]
25. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma.
Li J; Liu X; Cui Z; Han G
Med Sci Monit; 2020 Jun; 26():e922070. PubMed ID: 32578582
[TBL] [Abstract][Full Text] [Related]
26. Identification of host transcriptome-guided repurposable drugs for SARS-CoV-1 infections and their validation with SARS-CoV-2 infections by using the integrated bioinformatics approaches.
Ahmed FF; Reza MS; Sarker MS; Islam MS; Mosharaf MP; Hasan S; Mollah MNH
PLoS One; 2022; 17(4):e0266124. PubMed ID: 35390032
[TBL] [Abstract][Full Text] [Related]
27. TOP2A and CENPF are synergistic master regulators activated in cervical cancer.
Yu B; Chen L; Zhang W; Li Y; Zhang Y; Gao Y; Teng X; Zou L; Wang Q; Jia H; Liu X; Zheng H; Hou P; Yu H; Sun Y; Zhang Z; Zhang P; Zhang L
BMC Med Genomics; 2020 Oct; 13(1):145. PubMed ID: 33023625
[TBL] [Abstract][Full Text] [Related]
28. Identification of novel biomarkers in breast cancer via integrated bioinformatics analysis and experimental validation.
Wang N; Zhang H; Li D; Jiang C; Zhao H; Teng Y
Bioengineered; 2021 Dec; 12(2):12431-12446. PubMed ID: 34895070
[TBL] [Abstract][Full Text] [Related]
29. Analysis of potential key genes in very early hepatocellular carcinoma.
Wu M; Liu Z; Li X; Zhang A; Lin D; Li N
World J Surg Oncol; 2019 May; 17(1):77. PubMed ID: 31043166
[TBL] [Abstract][Full Text] [Related]
30. Interactive bioinformatics analysis for the screening of hub genes and molecular docking of phytochemicals present in kitchen spices to inhibit CDK1 in cervical cancer.
Vaghasia H; Sakaria S; Prajapati J; Saraf M; Rawal RM
Comput Biol Med; 2022 Oct; 149():105994. PubMed ID: 36103746
[TBL] [Abstract][Full Text] [Related]
31. Identification of
Zang Y; Zhao R; Wang T; Gao Y; Chen L; Liu S; Wang Y; Xue F
Mol Med Rep; 2023 Jun; 27(6):. PubMed ID: 37114556
[TBL] [Abstract][Full Text] [Related]
32. Identification of novel biomarkers and small molecule drugs in human colorectal cancer by microarray and bioinformatics analysis.
Chen J; Wang Z; Shen X; Cui X; Guo Y
Mol Genet Genomic Med; 2019 Jul; 7(7):e00713. PubMed ID: 31087508
[TBL] [Abstract][Full Text] [Related]
33. Robust Identification of Differential Gene Expression Patterns from Multiple Transcriptomics Datasets for Early Diagnosis, Prognosis, and Therapies for Breast Cancer.
Tuly KF; Hossen MB; Islam MA; Kibria MK; Alam MS; Harun-Or-Roshid M; Begum AA; Hasan S; Mahumud RA; Mollah MNH
Medicina (Kaunas); 2023 Sep; 59(10):. PubMed ID: 37893423
[No Abstract] [Full Text] [Related]
34. Identification of Core Prognosis-Related Candidate Genes in Cervical Cancer via Integrated Bioinformatical Analysis.
Wei J; Wang Y; Shi K; Wang Y
Biomed Res Int; 2020; 2020():8959210. PubMed ID: 32258155
[TBL] [Abstract][Full Text] [Related]
35. Identification of Key Genes and Pathways in Cervical Cancer by Bioinformatics Analysis.
Wu X; Peng L; Zhang Y; Chen S; Lei Q; Li G; Zhang C
Int J Med Sci; 2019; 16(6):800-812. PubMed ID: 31337953
[TBL] [Abstract][Full Text] [Related]
36. Identification of key genes and pathways of diagnosis and prognosis in cervical cancer by bioinformatics analysis.
Yang HJ; Xue JM; Li J; Wan LH; Zhu YX
Mol Genet Genomic Med; 2020 Jun; 8(6):e1200. PubMed ID: 32181600
[TBL] [Abstract][Full Text] [Related]
37. Bioinformatics analysis of the transcriptional expression of minichromosome maintenance proteins as potential indicators of survival in patients with cervical cancer.
Wu B; Xi S
BMC Cancer; 2021 Aug; 21(1):928. PubMed ID: 34404366
[TBL] [Abstract][Full Text] [Related]
38. Screening key genes and signaling pathways in colorectal cancer by integrated bioinformatics analysis.
Yu C; Chen F; Jiang J; Zhang H; Zhou M
Mol Med Rep; 2019 Aug; 20(2):1259-1269. PubMed ID: 31173250
[TBL] [Abstract][Full Text] [Related]
39. Bioinformatics analysis to identify breast cancer-related potential targets and candidate small molecule drugs.
Hong H; Chen H; Zhao J; Qin L; Li H; Huo H; Shi S
Mutat Res; 2023; 827():111830. PubMed ID: 37437506
[TBL] [Abstract][Full Text] [Related]
40. Identification of crucial aberrantly methylated and differentially expressed genes related to cervical cancer using an integrated bioinformatics analysis.
Ma X; Liu J; Wang H; Jiang Y; Wan Y; Xia Y; Cheng W
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32368784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]